How are cases spreading in the UK and how are we trying to curb their spread?
In London, the continuous seven-day rate on 15 January stood at 703.7 cases per 100,000 people, down from 1,053.4 the previous week and the lowest from seven days to 19 December. .
Currently, the east of England has a seven-day rate of 526.8, from 763.5 and the lowest since 20 December.
In the East Midlands, the rate fell from 478.1 during the seven days on January 8 to 402.8 during the seven days on January 15, and in the West Midlands it fell from 647.8 to 571.9,4.
The south-west of England recorded a smaller drop during the week, from 401.3 to 343.2, the lowest since 1 January.
Currently, the North East of England stands at 335.2, from 433.3, while Yorkshire & the Humber stands at 259.1, the lowest regional rate in England, at 335.5.
In the North West of England, the rate has fallen from 646.4 to 528.6.
The UK became the first Western country to start administering the coronavirus vaccine and the government hopes that mass vaccination can help slow the rate of infection, especially among the most vulnerable generation.
A total of 7,044,048 vaccines against Covid-19 had been carried out in England between 8 December and 25 January, according to provisional data from the NHS England, including the first and second doses, an increase of 221,067 with respect to the data of the previous day.
Of this figure, 6,573,570 were the first dose of the vaccine, an increase of 220,249 over the previous day’s figures, while 470,478 were the second dose, an increase of 818.
Johnson has pledged that the NHS is committed to providing vaccination to everyone in the top four priority groups by 15 February.
In total, 250 active hospitals, 50 vaccination centers and nearly 1,200 local vaccination sites will be established, including primary care networks, community pharmacy centers and mobile equipment, to ensure that all people at risk have easy access. to a vaccination center. regardless of where they live.
The Armed Forces, which are designed to help run mass vaccination centers at sports stadiums and public venues, will also contribute to this “unprecedented national effort.”
The Government has ordered about 100 million Oxford expressions, with 40 million to be launched in March. The regulatory agency for medicines and health products also approved the Modern vaccine for use on January 8, which will be delivered in the spring.
But what about the new strain?
On December 14, in his speech to the Commons, the health secretary also announced that a new variant of the coronavirus had been identified in England that has led to a rapid increase in cases in London and the south-east of England.
In England there has been a “relative increase” in this new variant in all areas, said Professor Whitty, which is “spreading across the country.”
The fastest increases occurred in the east, south-east and London, but “it is now taking off in other areas as well,” he said at a news conference on January 5th.
However, Sir Patrick Vallance said on 22 January that there was “growing confidence” that the UK variant would be susceptible to the vaccine.
The chief scientific adviser told the Downing Street press conference: “Laboratory studies believe the variant in the UK will be susceptible to vaccines.
“There is a growing confidence, along with a very important clinical observation, that people who have been previously infected and generated antibodies appear to be equally protected against the original virus and new variants.”
Although Boris Johnson also announced on January 22 that the British variant of the coronavirus could be up to 30 per cent more deadly than the original.
Professor Neil Ferguson, who is on Nervtag, the government’s virus advisory committee, said the latest data show that up to 13 people out of every 60 contract of the variant variety could die, compared to 10 out of 1000 who captured the original variant.
“It is a realistic possibility that the new UK variant will increase the risk of death, but considerable uncertainty remains,” Professor Ferguson told ITV.
“Four groups (Imperial, LSHTM, PHE and Exeter) have analyzed the relationship between people who test positive for the variant versus old strains and the risk of death.”
The professor said the available data on the new variant is incomplete, but there is a “signal” that there is a “1.3% increase in the risk of death.”
Moderna Inc. confirmed on January 25 that its vaccine produces virus-neutralizing antibodies in laboratory tests against new variants of coronavirus found in the UK and South Africa. The vaccine was approved for use by the Medicines and Health Products Regulatory Agency (MHRA) on 8 January and will be delivered to the UK in the spring.
Read more: What exactly is the Pfizer vaccine, who will get it and is it safe?